Reaction Biology’s ProLiFiler service provides in-depth bioinformatics analysis for researchers studying the therapeutic efficacy of their drug candidates. Our MoA finder provides sophisticated data, enabling the identification of the MoA (mode of action) by comparing screening profiles of over 900 drugs with a known MoA. The Biomarker Analysis helps in identifying the signature of responders to the test compound, helping researchers to focus on that specific cohort of patients who are to ultimately receive the treatment.
Advantages of ProLiFiler Bioinformatics Analysis:
- Analysis performed by a data scientist.
- Data interpretation supported by scientists.
- Custom-tailored add-ons available.
Save the date: The next screening schedule for ProLiFiler will be on 20th September 2021.
|